Short Interest in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Declines By 76.3%

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a large decrease in short interest in the month of January. As of January 30th, there was short interest totaling 9,581 shares, a decrease of 76.3% from the January 15th total of 40,386 shares. Approximately 0.3% of the company’s stock are sold short. Based on an average trading volume of 26,462 shares, the days-to-cover ratio is presently 0.4 days. Based on an average trading volume of 26,462 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.3% of the company’s stock are sold short.

Hedge Funds Weigh In On Invesco Pharmaceuticals ETF

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Joseph Group Capital Management grew its stake in Invesco Pharmaceuticals ETF by 9.9% during the 2nd quarter. Joseph Group Capital Management now owns 21,242 shares of the company’s stock valued at $1,697,000 after purchasing an additional 1,907 shares in the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of Invesco Pharmaceuticals ETF by 5.6% during the 2nd quarter. Envestnet Asset Management Inc. now owns 19,547 shares of the company’s stock valued at $1,561,000 after buying an additional 1,040 shares during the last quarter. AE Wealth Management LLC grew its position in shares of Invesco Pharmaceuticals ETF by 21.5% during the second quarter. AE Wealth Management LLC now owns 717 shares of the company’s stock worth $57,000 after buying an additional 127 shares in the last quarter. International Assets Investment Management LLC bought a new stake in shares of Invesco Pharmaceuticals ETF in the fourth quarter worth $64,000. Finally, Summit Wealth Group LLC Co. bought a new stake in shares of Invesco Pharmaceuticals ETF in the fourth quarter worth $445,000.

Invesco Pharmaceuticals ETF Trading Down 0.5%

NYSEARCA PJP opened at $108.99 on Friday. The stock has a market cap of $416.34 million, a P/E ratio of 15.59 and a beta of 0.50. The company’s fifty day simple moving average is $106.15 and its 200-day simple moving average is $98.25. Invesco Pharmaceuticals ETF has a 52 week low of $72.25 and a 52 week high of $110.54.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.